DEF 14A

Company

Phio Pharmaceuticals Corp.

Filed

April 30, 2021

Period of Report

June 15, 2021

Accession Number

0001683168-21-001666

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →